{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "12064-019",
      "generic_name": "doxorubicin hydrochloride",
      "labeler_name": "GlaxoSmithKline Manufacturing SpA",
      "active_ingredients": [
        {
          "name": "DOXORUBICIN HYDROCHLORIDE",
          "strength": "2 mg/mL"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "12064-019-00",
          "description": "98 VIAL in 1 CASE (12064-019-00)  / 10 mL in 1 VIAL",
          "marketing_start_date": "01-JAN-15"
        },
        {
          "package_ndc": "12064-019-01",
          "description": "50 VIAL in 1 CASE (12064-019-01)  / 25 mL in 1 VIAL",
          "marketing_start_date": "01-JAN-15"
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "INJECTION, SUSPENSION, LIPOSOMAL",
      "spl_id": "cc45ecda-93b1-4414-baee-7cc69252bc09",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20150101",
      "product_id": "12064-019_cc45ecda-93b1-4414-baee-7cc69252bc09",
      "brand_name_base": null
    }
  ]
}